Aastha Biocare Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 04-12-2024
- Paid Up Capital ₹ 1.74 M
as on 04-12-2024
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.80 Cr
as on 04-12-2024
- Revenue -99.93%
(FY 2022)
- Profit -100.08%
(FY 2022)
- Ebitda -100.05%
(FY 2022)
- Net Worth -99.92%
(FY 2022)
- Total Assets -99.84%
(FY 2022)
About Aastha Biocare
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.74 M.
The company currently has active open charges totaling ₹1.80 Cr.
Shankar Gangaram and Virendra Singh serve as directors at the Company.
- CIN/LLPIN
U51221MH2007PTC177116
- Company No.
177116
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Jalna, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aastha Biocare Private Limited offer?
Aastha Biocare Private Limited offers a wide range of products and services, including Cooking Spices and Masala, Dried Chillies & Pepper, Fresh, Dried & Preserved Fruits, Fresh Fruits, Fresh, Dried & Preserved Vegetables, Fresh Vegetables, Dry Fruits & Nuts, Peanut, Fertilizers and Soil Additives, Organic Fertilizers and Manure.
Who are the key members and board of directors at Aastha Biocare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Virendra Singh  | Director | 27-Dec-2007 | Current |
| Shankar Gangaram | Director | 27-Dec-2007 | Current |
Financial Performance of Aastha Biocare.
Aastha Biocare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.93% decrease. The company also saw a substantial fall in profitability, with a 100.08% decrease in profit. The company's net worth observed a substantial decline by a decrease of 99.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aastha Biocare?
In 2021, Aastha Biocare had a promoter holding of 74.00% and a public holding of 26.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 30 Sep 2009 | ₹1.80 Cr | Open |
How Many Employees Work at Aastha Biocare?
Unlock and access historical data on people associated with Aastha Biocare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aastha Biocare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aastha Biocare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
